Akebia Therapeutics (AKBA) has released an update to notify the public and investors about the unregistered sales of equity securities.
The summary of this text is that details provided in a previous section regarding a Warrant are also applicable and included in the current section for further reference.
For further insights into AKBA stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
